pyrazinoic acid has been researched along with Chronic Kidney Failure in 1 studies
pyrazinoic acid: active metabolite of pyrazinamide; structure
pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Bioavailability of pyrazinamide was only slightly increased in patients, its dialysis extraction coefficient being 55." | 1.27 | Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure. ( Farinotti, R; Fessi, H; Kenouch, S; Méry, JP; Montes, C; Stamatakis, G; Trouvin, JH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stamatakis, G | 1 |
| Montes, C | 1 |
| Trouvin, JH | 1 |
| Farinotti, R | 1 |
| Fessi, H | 1 |
| Kenouch, S | 1 |
| Méry, JP | 1 |
1 other study available for pyrazinoic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure.
Topics: Adult; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Tuberculosi | 1988 |